Our Pricing

Mounjaro or Saxenda Online Prescription UK: Which Weight Loss Injection Is Right for You?

Published on: June 03, 2026

Choosing between Mounjaro or Saxenda online prescription UK services requires understanding how these medications differ in mechanism, dosing, and clinical outcomes. At Cured Pharmacy, our UK-registered prescribers assess your medical history during a free online consultation to determine which treatment may be most suitable for your weight loss goals, with transparent pricing from £135.00 for Saxenda and £135.00 for Mounjaro.

How Mounjaro and Saxenda Work Differently

Mounjaro (tirzepatide) is the UK's first dual GIP/GLP-1 receptor agonist, activating two distinct hormonal pathways that regulate appetite, blood sugar, and energy metabolism [1]. This dual mechanism produces significantly greater weight reduction compared to single-pathway treatments, with clinical trials demonstrating average body weight reductions of 22.5% over 72 weeks at the highest maintenance dose [1].

Saxenda (liraglutide) is a GLP-1 receptor agonist that mimics a single natural hormone involved in appetite regulation and glucose control [2]. Licensed in the UK since 2015, Saxenda works by slowing gastric emptying and increasing feelings of fullness after meals, leading to reduced calorie intake. In the SCALE clinical programme, patients achieved an average weight loss of 8% over 56 weeks when combined with lifestyle modifications [2].

The fundamental difference lies in receptor activation: Mounjaro's dual action on both GIP and GLP-1 receptors typically produces more pronounced weight loss, whilst Saxenda's single-pathway mechanism offers a well-established safety profile with over eight years of UK clinical use [1][2].

Mounjaro vs Saxenda: Dosing and Administration

Mounjaro is administered once weekly via subcutaneous injection, starting at 2.5 mg for the first four weeks before gradually increasing to a maintenance dose between 5 mg and 15 mg, depending on individual response and tolerability [3]. The KwikPen device delivers pre-measured doses, requiring no manual dose adjustment, and patients typically inject on the same day each week into the abdomen, thigh, or upper arm.

Saxenda requires daily subcutaneous injections, beginning at 0.6 mg and increasing by 0.6 mg weekly until reaching the maintenance dose of 3.0 mg daily [4]. This daily regimen demands greater treatment adherence but allows more frequent dose adjustments if side effects occur. The pre-filled pen contains multiple doses, and patients must manually select the correct dose before each injection.

Your UK prescriber will consider your lifestyle, ability to maintain daily versus weekly injections, and previous experience with injectable medications when recommending between these treatments during your online consultation.

Injection Technique and Storage Requirements

Both medications must be stored in a refrigerator between 2°C and 8°C before first use, though Mounjaro pens may be kept at room temperature (below 30°C) for up to 21 days once in use, whilst Saxenda pens can remain unrefrigerated for 30 days [3][4]. Proper injection technique—rotating injection sites and ensuring the needle remains under the skin for the full injection duration—minimises bruising and ensures accurate dosing. Our pharmacy team provides detailed administration guidance with every prescription dispensed.

Clinical Efficacy: Comparing Weight Loss Outcomes

Head-to-head comparisons show tirzepatide consistently outperforms liraglutide in weight reduction outcomes. In the SURPASS-3 trial, patients on Mounjaro 15 mg achieved mean weight loss of 22.5% over 72 weeks, compared to 8% average reduction observed with Saxenda in the SCALE trials over 56 weeks [1][2]. However, individual responses vary considerably based on baseline BMI, adherence to lifestyle modifications, and metabolic factors.

Saxenda demonstrates particular efficacy in patients with BMI 30-35 kg/m² who may not require the more intensive intervention that Mounjaro provides. The medication's longer UK market presence means prescribers have extensive real-world experience managing patients on liraglutide, including strategies for optimising outcomes and managing side effects [2].

Both treatments require ongoing commitment to dietary changes and increased physical activity. Clinical trials showing significant weight loss included structured lifestyle intervention programmes alongside medication, and your UK prescriber will discuss realistic expectations based on your individual circumstances during the online consultation [1][2].

Time to Therapeutic Effect

Most patients notice reduced appetite within the first two weeks of either treatment, though measurable weight loss typically becomes evident after 4-8 weeks [3][4]. Mounjaro's dose escalation schedule means maximum therapeutic effect may not be reached until week 20-24, whilst Saxenda reaches full maintenance dosing by week 5. Your prescriber will schedule follow-up assessments to monitor progress and adjust treatment as needed.

Side Effects and Tolerability Profiles

Gastrointestinal side effects are the most commonly reported adverse events with both medications, including nausea, diarrhoea, constipation, and abdominal discomfort [3][4]. These effects typically emerge during dose escalation and diminish over time as the body adjusts. In clinical trials, nausea affected approximately 44% of Mounjaro patients and 39% of Saxenda patients, though severe cases leading to treatment discontinuation occurred in fewer than 5% [1][2].

Mounjaro's once-weekly dosing may produce more pronounced but less frequent gastrointestinal symptoms compared to Saxenda's daily administration, which provides more consistent blood levels but requires daily tolerance. Some patients find the weekly injection schedule easier to manage around social events and travel, whilst others prefer the flexibility of adjusting daily doses if side effects occur [3].

Rare but serious side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other diabetes medications). Both treatments carry a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [3][4]. Your UK prescriber will assess your personal and family medical history for contraindications before prescribing either medication.

Who Can Get a Mounjaro or Saxenda Online Prescription UK

UK prescribers typically consider these medications for adults with BMI ≥30 kg/m², or BMI ≥27 kg/m² with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [5]. During your online consultation at Cured Pharmacy, our UK-registered clinicians review your medical history, current medications, and weight loss goals to determine eligibility and suitability for either treatment.

Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and pregnancy or breastfeeding [3][4]. Patients with a history of pancreatitis require careful assessment, and those taking insulin or sulfonylureas need dose adjustments to prevent hypoglycaemia when starting GLP-1 therapy.

The online consultation process takes under three minutes and includes questions about your weight history, previous weight loss attempts, current health conditions, and medications. If approved, your prescription is sent electronically to our UK pharmacy, and medication is dispensed for next-day delivery in discreet packaging. All consultations are reviewed by UK-registered prescribers, with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing clinical governance.

Ongoing Monitoring Requirements

Both treatments require regular follow-up to assess efficacy, tolerability, and appropriateness for continued use. NICE guidance recommends discontinuing therapy if patients do not achieve at least 5% weight loss after 12 weeks at maintenance dose [5]. Your prescriber will schedule review consultations to monitor progress, adjust dosing, and ensure treatment remains clinically appropriate. Blood pressure, heart rate, and kidney function should be monitored periodically, particularly in patients with pre-existing cardiovascular or renal conditions.

Cost Comparison and Prescription Process at Cured Pharmacy

Transparent pricing is essential when comparing weight loss treatments. At Cured Pharmacy, Saxenda prescriptions start from £135.00 whilst Mounjaro is available from £124.99 with final costs determined by your prescribed dose and treatment duration. These prices include the medication, UK prescriber consultation, and discreet home delivery—no hidden fees or subscription commitments.

The prescription process begins with a free online consultation accessible 24/7 through our website. After completing the medical questionnaire, a UK-registered prescriber reviews your information, typically within hours during business days. If approved, you'll receive electronic confirmation and tracking information once your medication is dispatched from our GPhC-registered pharmacy (9012511).

We stock only genuine UK-licensed medications sourced directly from licensed wholesalers, ensuring every pen dispensed meets MHRA quality standards. Our pharmacy team is available on (+44) 116 4646009 for questions about your prescription, administration technique, or managing side effects. Repeat prescriptions can be requested through your online account, with the same clinical review process ensuring ongoing appropriateness of treatment.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14881 [accessed 13 August 2026]
4. Electronic Medicines Compendium. (2023). Saxenda 6 mg/ml solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/2313 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to lifestyle modifications alongside medication therapy.